Oxidation increases mucin polymer cross-links to stiffen airway mucus gels
- PMID: 25717100
- PMCID: PMC4403633
- DOI: 10.1126/scitranslmed.3010525
Oxidation increases mucin polymer cross-links to stiffen airway mucus gels
Abstract
Airway mucus in cystic fibrosis (CF) is highly elastic, but the mechanism behind this pathology is unclear. We hypothesized that the biophysical properties of CF mucus are altered because of neutrophilic oxidative stress. Using confocal imaging, rheology, and biochemical measures of inflammation and oxidation, we found that CF airway mucus gels have a molecular architecture characterized by a core of mucin covered by a web of DNA and a rheological profile characterized by high elasticity that can be normalized by chemical reduction. We also found that high levels of reactive oxygen species in CF mucus correlated positively and significantly with high concentrations of the oxidized products of cysteine (disulfide cross-links). To directly determine whether oxidation can cross-link mucins to increase mucus elasticity, we exposed induced sputum from healthy subjects to oxidizing stimuli and found a marked and thiol-dependent increase in sputum elasticity. Targeting mucin disulfide cross-links using current thiol-amino structures such as N-acetylcysteine (NAC) requires high drug concentrations to have mucolytic effects. We therefore synthesized a thiol-carbohydrate structure (methyl 6-thio-6-deoxy-α-D-galactopyranoside) and found that it had stronger reducing activity than NAC and more potent and fast-acting mucolytic activity in CF sputum. Thus, oxidation arising from airway inflammation or environmental exposure contributes to pathologic mucus gel formation in the lung, which suggests that it can be targeted by thiol-modified carbohydrates.
Copyright © 2015, American Association for the Advancement of Science.
Conflict of interest statement
Figures
References
-
- Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459–486. - PubMed
-
- Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM. Muc5b is required for airway defence. Nature. 2014;505:412–416. - PMC - PubMed
-
- King M. Physiology of mucus clearance. Paediatr Respir Rev. 2006;7(Suppl. 1):S212–S214. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 HL107202/HL/NHLBI NIH HHS/United States
- P30 DK072517/DK/NIDDK NIH HHS/United States
- P01 HL081064/HL/NHLBI NIH HHS/United States
- P50HL107191/HL/NHLBI NIH HHS/United States
- P01HL103453/HL/NHLBI NIH HHS/United States
- R01 HL080414/HL/NHLBI NIH HHS/United States
- U10 HL109146/HL/NHLBI NIH HHS/United States
- U10 HL109250/HL/NHLBI NIH HHS/United States
- R01HL080414/HL/NHLBI NIH HHS/United States
- P50 HL107191/HL/NHLBI NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- R24 HL123767/HL/NHLBI NIH HHS/United States
- P01 HL103453/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
